 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «12 |
- ||||| Mosquirix (RTS,S) / GSK
Trial initiation date, Trial primary completion date: Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine. (clinicaltrials.gov) - May 2, 2016
P3, N=699, Not yet recruiting, Sponsor: GlaxoSmithKline
Initiation date: Sep 2016 --> Jun 2016 | Trial primary completion date: Oct 2017 --> Jun 2017
- Stamaril (yellow fever vaccine) / Sanofi, Ixiaro (IC51) / Valneva
Trial completion: The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans (clinicaltrials.gov) - Apr 20, 2016
P2, N=84, Completed, Sponsor: Singapore General Hospital
Initiation date: Sep 2016 --> Jun 2016 | Trial primary completion date: Oct 2017 --> Jun 2017 Active, not recruiting --> Completed
- |||||||||| Mosquirix (RTS,S) / GSK
New P3 trial: Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine. (clinicaltrials.gov) - Mar 4, 2016
P3, N=699, Not yet recruiting, Sponsor: GlaxoSmithKline
- Biomarker, Phase classification: Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=48, Completed, Sponsor: University of Surrey
Active, not recruiting --> Completed Phase classification: P1 --> P=N/A
- Stamaril (yellow fever vaccine) / Sanofi, Ixiaro (IC51) / Valneva
Enrollment closed: The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans (clinicaltrials.gov) - Dec 6, 2014
P2, N=100, Active, not recruiting, Sponsor: Singapore General Hospital
Phase classification: P1 --> P=N/A Recruiting --> Active, not recruiting
- Stamaril (yellow fever vaccine) / Sanofi
Trial primary completion date: The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. (clinicaltrials.gov) - Jul 23, 2014
P3, N=71, Active, not recruiting, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting --> Active, not recruiting Trial primary completion date: May 2012 --> May 2017
- Biomarker, Trial primary completion date: Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines (clinicaltrials.gov) - May 6, 2014
P1, N=48, Completed, Sponsor: University of Surrey
Trial primary completion date: May 2012 --> May 2017 Trial primary completion date: Dec 2013 --> Jan 2014
- Biomarker, Enrollment change: Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines (clinicaltrials.gov) - May 6, 2014
P1, N=48, Completed, Sponsor: University of Surrey
Trial primary completion date: Dec 2013 --> Jan 2014 N=24 --> 48
- | Biomarker, Trial completion: Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines (clinicaltrials.gov) - May 6, 2014
P1, N=48, Completed, Sponsor: University of Surrey
N=24 --> 48 Recruiting --> Completed
- ||||||| Stamaril (yellow fever vaccine) / Sanofi, YF-VAX (yellow fever vaccine) / Sanofi, Dengvaxia (Dengue vaccine) / Sanofi
Trial completion: Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers (clinicaltrials.gov) - Mar 31, 2014
P3, N=792, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
Recruiting --> Completed Active, not recruiting --> Completed
- Stamaril (yellow fever vaccine) / Sanofi, Ixiaro (IC51) / Valneva
Enrollment open: The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans (clinicaltrials.gov) - Oct 5, 2013
P2, N=100, Recruiting, Sponsor: Singapore General Hospital
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Biomarker, Trial initiation date: Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines (clinicaltrials.gov) - Sep 16, 2013
P1, N=24, Recruiting, Sponsor: University of Surrey
Not yet recruiting --> Recruiting Initiation date: Jan 2013 --> Sep 2013
- Biomarker, Enrollment open: Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines (clinicaltrials.gov) - Sep 16, 2013
P1, N=24, Recruiting, Sponsor: University of Surrey
Initiation date: Jan 2013 --> Sep 2013 Not yet recruiting --> Recruiting
- | Stamaril (yellow fever vaccine) / Sanofi, Ixiaro (IC51) / Valneva
New P2 trial: The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans (clinicaltrials.gov) - Sep 12, 2013
P2, N=100, Recruiting, Sponsor: Singapore General Hospital
- |||| Synflorix (10-valent pneumococcal conjugate vaccine) / GSK, pneumococcal recombinant vaccine (GSK 2189242A) / GSK
Trial completion: Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants (clinicaltrials.gov) - Apr 4, 2013
P2, N=1320, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Biomarker, New P1 trial: Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines (clinicaltrials.gov) - Jan 8, 2013
P1, N=24, Recruiting, Sponsor: University of Surrey
- | Stamaril (yellow fever vaccine) / Sanofi
Enrollment change: The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. (clinicaltrials.gov) - Aug 23, 2012
P3, N=71, Active, not recruiting, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Active, not recruiting --> Completed N=57 --> 71
- | Stamaril (yellow fever vaccine) / Sanofi
Enrollment closed: The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. (clinicaltrials.gov) - Aug 23, 2012
P3, N=71, Active, not recruiting, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
N=57 --> 71 Completed --> Active, not recruiting
- |||||||||| Stamaril (yellow fever vaccine) / Sanofi, YF-VAX (yellow fever vaccine) / Sanofi, Dengvaxia (Dengue vaccine) / Sanofi
New P3 trial: Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers (clinicaltrials.gov) - Sep 15, 2011
P3, N=792, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
- || Stamaril (yellow fever vaccine) / Sanofi
New P3 trial: The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. (clinicaltrials.gov) - Aug 29, 2011
P3, N=71, Active, not recruiting, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis